Murdo Gordon - Nov 2, 2021 Form 4 Insider Report for AMGEN INC (AMGN)

Role
EVP Global Commercial Ops
Signature
/s/ Murdo Gordon
Stock symbol
AMGN
Transactions as of
Nov 2, 2021
Transactions value $
-$1,171,677
Form type
4
Date filed
11/3/2021, 07:26 PM
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -$1.17 M -5.59 K -12.36% $209.79 39.6 K Nov 2, 2021 Direct F1, F2

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units granted under the Company's equity plans: 3,023 RSUs which vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,172 RSUs which vest in installments of 1,376 on 4/30/2023, 1,377 on 4/30/2024 and 1,419 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 447 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.